-
Man City midfield trio backed to emulate Rodri and Silva
-
Fitzpatrick 'not comfortable' over Dubai golf finale
-
'We're losing control,' AI pioneer Yoshua Bengio tells AFP
-
Gaza apartment block collapse kills 21, including 12 children
-
WHO eyes 'encouraging' signs in DRCongo fight against Ebola
-
Gaza apartment block collapse leaves 21 dead
-
Liga boss criticises Real Madrid trio for Ceuta shirt incident
-
US House targets data centers as midterm backlash grows
-
WTA Finals moved to Charlotte from 2027
-
French ex-minister Dati goes on trial in Renault-Nissan corruption case
-
Almost 8,000 excess deaths in France's scorched summer: statistics
-
'Being Heumann' captures joy in fight for disability rights
-
Ex-president's lengthy war crimes sentence shocks Kosovo
-
Retired great Nadal to play in exhibition matches
-
US House faces test on sweeping Russia sanctions bill
-
IR-MED and Dice Technologies Announce collaboration to Evaluate and Advance Pressure-Injury Prevention Platform in Japan
-
British PM says to make 'difficult decisions' as inflation rises
-
Watts, Pitt, Cruz to light up Spain's top film festival
-
TotalEnergies pumps up controversy in France with cut-price gas
-
Sweden expels Iran embassy employee over anti-Jewish threats
-
Global fuel price demos: a round-up
-
Toogood Gold's Table Mountain Sits in the Shadow of a Nevada Gold Rush
-
Leverate Launches MCP for Traders to Connect AI Assistants With Trading Platforms
-
MEXC July–August Security Report: 38.66M USDT in Risk Funds Intercepted, Futures Insurance Fund Hits 792M USDT
-
MEXC Launches $1M "Discover Your Wall Street DNA" Campaign to Help Traders Find Their Market Fit
-
'Breathing toxin every day': Indonesians choked by haze feel helpless
-
Emporio Armani names Dario Vitale new creative director
-
Stocks edge higher ahead of US Fed rate call
-
Maresca defends VAR officials after Man City benefit from error
-
Philippines ex-leader Duterte makes first in-person ICC appearance
-
Courts jails LGBTQ activists as Turkey crackdown widens
-
2027 Formula One calendar includes Monaco sprint race
-
French court to hear Depardieu's appeal against rape trial order: sources
-
Palestinians are the real victims, Thunberg tells Ed Sheeran
-
The German state premier hoping to halt far-right surge
-
Hashim Thaci: From 'George Washington of Kosovo' to Hague convict
-
Lebanon wants Israel security deal as prelude to peace: president to AFP
-
Amnesty says Iran committed 'crimes against humanity' in crackdown on 2022 protests
-
England's Brook keen to learn from 'hero' Pietersen after stunning ton
-
EU to ban social media for under 13s, curb access until 15
-
Saudi says Houthis target Mecca, warns of 'red line'
-
Philippines ex-leader Duterte makes first appearance at ICC
-
Phillippines ex-leader Duterte makes first appearance at ICC
-
EU chief pitches 'associate member' status for Canada
-
Lebanon wants Israel security deal, Hezbollah disarmament without confrontation: president to AFP
-
English village votes to 'secede' from UK over asylum centre plan
-
BASIS.pro Expands On-Chain Infrastructure with XDC Network Partnership and Zypher DAO as Auto Earn Goes Live
-
Wildfires push endangered Sumatran elephants to brink: Indonesian NGO
-
Samson relishing battle with teen star Sooryavanshi for India spot
-
Stocks head higher as traders prepare for Fed decision
WHO eyes 'encouraging' signs in DRCongo fight against Ebola
The Ebola epidemic in the Democratic Republic of Congo is still spreading but appears to be showing "encouraging" signs of improvement, the head of the World Health Organization said on Wednesday.
"We are starting to see encouraging signs that we're gaining ground," Tedros Adhanom Ghebreyesus told a news conference in Geneva.
Since the DRC declared its 17th Ebola outbreak in mid-May, more than 3,500 deaths have been recorded from over 7,200 cases to date across seven northern and eastern provinces plagued by widespread insecurity and a litany of armed groups.
Ebola, which is transmitted through contact with bodily fluids and can cause severe internal and external bleeding and organ failure, has killed more than 15,000 people in Africa over the last 50 years.
Tedros said that transmission was declining in the worst-affected areas of Ituri province, the epicentre of the outbreak, while South Kivu has not reported any new cases since May.
"Trials of treatments and post-exposure prophylaxis are picking up speed, due to increased community engagement," he added.
"Vaccine trials should begin in the coming weeks," Tedros said, while warning against complacency. "Make no mistake: the epidemic continues to grow and continues to kill," he said.
"We still have many, many months ahead of us," added Maria Van Kerkhove, director of epidemic and pandemic management at the UN health agency.
- Right response -
In North Kivu, the number of cases was rising "fast", Tedros said, with weekly cases almost doubling from about 100 to more than 200.
"The area is so vast that it is hard to speak of a single epidemic. It is many outbreaks, in many places. We must get the response right in every one of them," he added.
The remoteness of the province, high population mobility and attacks on humanitarian workers were further complicating efforts to fight the epidemic, he explained.
The Africa Centres for Disease Control and Prevention (CDC) and the WHO issued a funding appeal in June for $518 million to support the epidemic response until November.
Both organisations and the Congolese government earlier this month launched a new bid for $1.3 billion for the next six months, on top of the $1.1 billion requested by the UN in August for humanitarian assistance, WHO health emergencies chief Chikwe Ihekweazu said.
There is currently no approved vaccine or treatment against the Bundibugyo strain responsible for the current outbreak.
Some 70,000 doses of the Ervebo vaccine, which has been approved against the Zaire strain of Ebola, have been sent to the DRC to assess its effects on tackling the spread of Bundibugyo.
More than 3,000 health workers and frontline staff have already been vaccinated in Kisangani, said Meg Doherty, director of science for health at the UN health agency.
An observational study led by the Doctors Without Borders (MSF) charity will start on Saturday to evaluate the vaccine's effectiveness in reducing illness and death, she added.
Clinical trials of two vaccines in development against Bundibugyo will take place in the country on a date to be fixed.
T.Bondarenko--BTB